Marc Buyse, Sc.D. is the founder of IDDI (International Drug Development Institute), a company specialized in the design
and development of clinical trials, specifically in oncology. IDDI is the expert in biometry; biostatistics, data management and randomization.
Marc's previous experience includes 12 years at the EORTC, a key European academic oncology group.
Marc holds degrees in Engineering, Management and a doctorate in biostatistics from the Harvard School of Public Health.